drugset / Trial / NCT02602353

Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)

NCT02602353

Phase 2 Completed 42 enrolled Lead Chemical Co., Ltd. Cardinal Health · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the analgesic efficacy and safety of a new pain patch compared to placebo and no treatment in subjects experiencing Delayed Onset Muscle Soreness (DOMS).

Timeline

Start
2015-10
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Loxoprofen Small molecule Topical

Indications

No indication recorded.